Anthony Lombardo is reportedly leaving his position as head ofLockheed Martin Western Development Laboratories Medical ImagingSystems, according to sources close to the Hoffman Estates, IL,PACS developer. Lombardo is a former veteran of Philips'
Anthony Lombardo is reportedly leaving his position as head ofLockheed Martin Western Development Laboratories Medical ImagingSystems, according to sources close to the Hoffman Estates, IL,PACS developer. Lombardo is a former veteran of Philips' CommViewPACS project and has led the Lockheed Martin unit since its earlierincarnation, Loral Medical Imaging Systems (SCAN 9/14/94). Theunit became a part of Lockheed Martin after the defense contractorbought Loral earlier this year. Lockheed Martin representativesdeclined to comment on Lombardo's reported departure.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.